纵向队列中与系统性红斑狼疮亚型相关CpG位点甲基化动态变化
研究纳入101名加州狼疮流行病学研究参与者,在入组时和2年后采集血样,用Illumina EPIC BeadChip检测DNA甲基化。256个既往与SLE亚型相关的CpG中185个(72.3%)两年内保持稳定;亚型相关CpG变化比例(27.7%)高于全基因组背景(0.34%)。细胞类型比例变化与67个CpG变化相关,15个CpG与免疫抑制剂使用至少1项显著关联。
要点
- 256个SLE亚型相关CpG中185个(72.3%)在2年内保持稳定,可能作为疾病亚型生物标志物。
- 亚型相关CpG随时间变化比例为27.7%,高于全基因组背景的0.34%。
- 细胞类型比例变化与67个CpG变化相关,15个CpG与免疫抑制剂使用至少1项显著关联。
核心结论
- 在纵向SLE队列中,一部分SLE亚型相关CpG随时间保持稳定,可能作为疾病亚型的生物标志物。
- 另一部分SLE亚型相关CpG的变化比例高于全基因组甲基化组。
- 需要额外研究来理解这些变化对SLE相关CpG甲基化的病因学和影响。
研究设计与样本
- 研究纳入加州狼疮流行病学研究(California Lupus Epidemiology Study)的101名参与者。
- 从入组时和2年后采集的血样中提取DNA,使用Illumina EPIC BeadChip试剂盒分析。
- 使用配对t检验识别全基因组变化,包括256个既往发现与SLE亚型相关的CpG位点。
- 建立线性混合模型分析DNA甲基化与疾病活动度、药物使用和样本细胞类型比例的关系,并校正年龄、性别和遗传主成分。
主要发现
- 256个既往确定的SLE亚型相关CpG中,185个(72.3%)在2年内保持稳定(t检验错误发现率>0.05)。
- 与全基因组背景甲基化相比,SLE亚型相关CpG随时间变化存在富集(27.7% vs 0.34%)。
- 细胞类型比例变化与67个CpG的变化相关(P < 2.70×10^-5)。
- 15个CpG与免疫抑制剂使用至少1项显著关联。
局限性
- 需要额外研究来理解这些变化对SLE相关CpG甲基化的病因学和影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Findings from cross-sectional studies have revealed associations between DNA methylation and systemic lupus erythematosus (SLE) outcomes. This study was undertaken to investigate the dynamics of DNA methylation by examining participants from an SLE longitudinal cohort using samples collected at 2 time points. METHODS: A total of 101 participants from the California Lupus Epidemiology Study were included in our analysis. DNA was extracted from blood samples collected at the time of enrolment in the cohort and samples collected after 2 years and was analyzed using Illumina EPIC BeadChip kit. Paired t-tests were used to identify genome-wide changes which included 256 CpG sites previously found to be associated with SLE subtypes. Linear mixed models were developed to understand the relationship between DNA methylation and disease activity, medication use, and sample cell-type proportions, adjusted for age, sex, and genetic principal components. RESULTS: The majority of CpGs that were previously determined to be associated with SLE subtypes remained stable over 2 years (185 CpGs [72.3%]; t-test false discovery rate >0.05). Compared to background genome-wide methylation, there was an enrichment of SLE subtype-associated CpGs that changed over time (27.7% versus 0.34%). Changes in cell-type proportions were associated with changes at 67 CpGs (P < 2.70 × 10-5 ), and 15 CpGs had at least 1 significant association with immunosuppressant use. CONCLUSION: In this longitudinal SLE cohort, we identified a subset of SLE subtype-associated CpGs that remained stable over time and may be useful as biomarkers of disease subtypes. Another subset of SLE subtype-associated CpGs changed at a higher proportion compared to the genome-wide methylome. Additional studies are needed to understand the etiology and impact of these changes on methylation of SLE-associated CpGs.
引用
- Lanata CM, Nititham J, Taylor KE, et al. Dynamics of Methylation of CpG Sites Associated With Systemic Lupus Erythematosus Subtypes in a Longitudinal Cohort. Arthritis Rheumatol. 2022. PMID: 35635730. doi:10.1002/art.42237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。